PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Fruit Advantage / Traverse Bay Farms

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Fruit Advantage Selected for the Fall Edition of Dolce Magazine - Dolce Magazine has chosen Fruit Advantage Heart Health Pomegranate Formula for the fall edition of the magazine - TraverseBayFarms.com
Fruit Advantage Selected for the Fall Edition of Dolce Magazine

 

NewswireToday - /newswire/ - Bellaire, MI, United States, 2007/10/19 - Dolce Magazine has chosen Fruit Advantage Heart Health Pomegranate Formula for the fall edition of the magazine - TraverseBayFarms.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dolce is an internationally recognized publisher of lifestyle magazines and Dolce also publishes books. The publisher caters to sophisticated audiences who appreciate the good things in life. “We are very excited we were selected for the fall edition of Dolce Magazine.”, says Andy LaPointe, director of Marketing for Fruit Advantage.

Fruit Advantage offers 5 proprietary fruit-based formulas, each offering the synergistic and natural health benefits of the underlying fruit. In fact, Fruit Advantage Tart Cherry delivers 1200mg of tart cherry in each daily serving. This equals the specific antioxidant value of over 5 glasses of tart cherry juice without the sugar.

The company offers the following fruit-supplement formulas: Fruit Advantage Heart Health (Pomegranate), Fruit Advantage Brain Support (Wild Blueberry), Fruit Advantage Women’s Formula (Cranberry) and Fruit Advantage Cherry Prime. Each formula is made using the skin and pulp of the underlying fruit, laboratory tested, has a certificate of analysis and tested for heavy metals.

According the Andy LaPointe, Director of Marketing with Fruit Advantage, “today’s active and hectic lifestyles, combined with the seasonality of fruit, may inhibit individuals the ability the fully enjoy fresh fruit on a daily basis, however, Fruit Advantage offers an excellent way of supplementing your daily intake of fruit-based antioxidants.”

In addition, to the Fruit Advantage fruit-based supplements, the company also offers Montmorency tart cherry juice concentrate and a complete line of dried fruit including dried tart cherries and wild blueberries. Contact Fruit Advantage toll-free at 1-877-746-7477

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Fruit Advantage / Traverse Bay Farms

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Fruit Advantage Selected for the Fall Edition of Dolce Magazine

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Andy LaPointe - FruitAdvantage.com 
231-533-8788
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Fruit Advantage / Traverse Bay Farms securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Fruit Advantage / Traverse Bay Farms / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)